Key References
- JONES TR, LERRS G, CL-IAN C-C, DAVIES P: Pharmacology and pathophysiology of leukotrienes. In: Leukotrienes and Lipoxygenases: Chemical, Biological and Clinical Aspects. (1989) Rokach J (Ed), Elsevier Science pp309–403.
- FORD-HUTCHINSON AW: Evidence for the involvement of leukotrienes and other lipoxyge-nase products in disease states. In: Leukotrienes and Lipoxygenases: Chemical, Biological and Clinical Aspects. (1989) Rokach J (Ed), Elsevier Science pp405–420.
- MASAMUNE H, MELVIN LS JR: Novel applications of leukotriene intervention. Annu. Rep. Med. Chem. (1989) 24:71.
- HUI KP, TAYLOR IK, TAYLOR GW, RUBIN P, KES'TERSON J, BARNES NC, BARNES PJ: Effects of a 5-lipoxygenase inhibitor on leukotriene generation and airway response after allergen challenge in asthmatic patients. Thorax (1991) 46:184.
- RASK-MADSEN J, BUKHAVE K, LANRSEN LS, LAURITSEN K: 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease. Agents Action (1992) C37.
- WEINBLATT M, KREMER J, HELFGOTT S, COBLYN J, MAIER A, SPERLING R, Ph IrRILLO G, KESTERSON J, DUBE L, HENSON B, TEOH N, RUBIN P: A 5-lipoxygenase inhibitor in rheumatoid arthritis. Arthritis Rheum. (1990) 33:S152.
- CARTER GW, YOUNG PR, ALBERT DH, BouskA J, DYER R, BELL RL, BOUSKA J, SUMMERS JB, BROOKS DW: 5-Lipoxygenase inhibitory activity of zileuton. J. Pharmacol Exp. Ther. (1991) 256:929.
- GARLAND LG, SALMON JA: Hydroxamic acids and hydroxyureas as inhibitors of arachidonate 5-lipoxygenase. Drugs Fut. (1991) 16:547.
- ELI LILLY & CO, US5028629.
- ELI LILLY & CO, US5130485.